Home ABO blood group: old dogma, new perspectives
Article
Licensed
Unlicensed Requires Authentication

ABO blood group: old dogma, new perspectives

  • Massimo Franchini

    Dr. Massimo Franchini was born in Verona (Italy) in 1966. After graduating in Medicine from the University of Verona (Italy) in 1991, he specialized in Hematology at the same university in 1995. He worked at the Immunohematology and Transfusion Medicine of the University Hospital of Verona until 2008 when he became Head of Transfusion Center of the University Hospital of Parma (Italy). Currently, he is Head of the Department of Hematology and Transfusion Medicine of the city Hospital of Mantova (Italy) and is associate editor of Blood Transfusion and Seminars in Thrombosis and Hemostasis.

     EMAIL logo     and Giancarlo Maria Liumbruno

    Dr. Giancarlo Maria Liumbruno was born in Mogadishu (Somalia) in 1961. After graduating in Medicine from the University of Pisa (Italy) in 1985, he specialized in Clinical Pathology (Immunohematology branch) at the same University in 1993. In 1995, he attained the diploma “Certificat d’Université d’Enseignement Européen de Transfusion Sanguine” at the Louis Pasteur University, Strasbourg (France) and in 2000 a Masters in “Healthcare management: principles, tools, methods” at the University of Florence (Italy). Currently, he is Head of the Immunohematology and Transfusion Medicine and Clinical Pathology Units at the “San Giovanni Calibita” Fatebenefratelli Hospital, Rome (Italy) and is associate editor of Blood Transfusion and member of the editorial board of the Journal of Blood Transfusion.
Published/Copyright: May 7, 2013
Become an author with De Gruyter Brill
Submit Manuscript Author Information
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Clinical Chemistry and Laboratory Medicine (CCLM) Volume 51 Issue 8

Abstract

Human blood group antigens are glycoproteins and glycolipids expressed on the surface of red blood cells and a variety of human tissues, including the epithelium, sensory neurons, platelets and the vascular endothelium. Accumulating evidence indicate that ABO blood type is implicated in the development of a number of human diseases, including cardiovascular and neoplastic disorders. In this review, beside its physiologic role in immunohematology and transfusion medicine, we summarize the current knowledge on the association between the ABO blood group and the risk of developing thrombotic events and cancers.

Keywords: ABO blood group; cancer; cardiovascular disorders; thrombosis; von Willebrand factor
Corresponding author: Massimo Franchini, Department of Transfusion Medicine and Hematology, Azienda Ospedaliera Carlo Poma, Mantova, Italy

About the authors

Massimo Franchini

Dr. Massimo Franchini was born in Verona (Italy) in 1966. After graduating in Medicine from the University of Verona (Italy) in 1991, he specialized in Hematology at the same university in 1995. He worked at the Immunohematology and Transfusion Medicine of the University Hospital of Verona until 2008 when he became Head of Transfusion Center of the University Hospital of Parma (Italy). Currently, he is Head of the Department of Hematology and Transfusion Medicine of the city Hospital of Mantova (Italy) and is associate editor of Blood Transfusion and Seminars in Thrombosis and Hemostasis.

Giancarlo Maria Liumbruno

Dr. Giancarlo Maria Liumbruno was born in Mogadishu (Somalia) in 1961. After graduating in Medicine from the University of Pisa (Italy) in 1985, he specialized in Clinical Pathology (Immunohematology branch) at the same University in 1993. In 1995, he attained the diploma “Certificat d’Université d’Enseignement Européen de Transfusion Sanguine” at the Louis Pasteur University, Strasbourg (France) and in 2000 a Masters in “Healthcare management: principles, tools, methods” at the University of Florence (Italy). Currently, he is Head of the Immunohematology and Transfusion Medicine and Clinical Pathology Units at the “San Giovanni Calibita” Fatebenefratelli Hospital, Rome (Italy) and is associate editor of Blood Transfusion and member of the editorial board of the Journal of Blood Transfusion.

References

1. Storry JR, Olsson ML. The ABO blood group system revisited: a review and update. Immunohematology 2009;25:48–59.10.21307/immunohematology-2019-231Search in Google Scholar PubMed

2. Eastlund T. The histo-blood group ABO system and tissue transplantation. Transfusion 1998;38:975–88.10.1046/j.1537-2995.1998.381098440863.xSearch in Google Scholar PubMed

3. Franchini M, Capra F, Targher G, Montagnana M, Lippi G. Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications. Thromb J 2007;5:14.10.1186/1477-9560-5-14Search in Google Scholar PubMed

4. Franchini M, Favaloro EJ, Targher G, Lippi G. ABO blood group, hypercoagulability, and cardiovascular and cancer risk. Crit Rev Clin Lab Sci 2012;49:137–49.10.3109/10408363.2012.708647Search in Google Scholar PubMed

5. Landsteiner K. Zur kenntnis der antifermentativen, lytischen und agglutinierenden wirkungendes des blutserums und der lymphe. Zentralbl Bakteriol 1900;27:357–63.Search in Google Scholar

6. Decastello A, Sturli A. Über die isoagglutinine im serum gesunder und kranker menschen. Munch Med Wochenschr 1902;49:1900–5.Search in Google Scholar

7. Springer GF. Blood-group and Forssman antigenic determinants shared between microbes and mammalian cells. Prog Allergy 1971;15:9–77.10.1159/000313046Search in Google Scholar PubMed

8. Daniel-Johnson J, Leitman S, Klein H, Alter H, Lee-Stroka A, Scheinberg P, et al. Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions. Transfusion 2009;49:1845–9.10.1111/j.1537-2995.2009.02208.xSearch in Google Scholar

9. Cooling L. ABO, H, and Lewis blood groups and structurally related antigens. In: Roback JD, Grossman BJ, Harris T, Hillyer CD, editors. Technical manual, 17th ed. Bethesda: AABB, 2011:363–87.Search in Google Scholar

10. Napier JAF, editor. Handbook of blood transfusion therapy, 2nd ed. Chichester: John Wiley & Sons Ltd, 1995:15.Search in Google Scholar

11. Mollison PL, Engelfriet CP, Contreras MK, editors. Blood transfusion in clinical medicine, 9th ed. Oxford: Blackwell Scientific Publications, 1993:150.Search in Google Scholar

12. Bloodbook.com. Racial and ethnic distribution of ABO blood types. Available from: http://www.bloodbook.com/world-abo.html. Accessed on 3 April, 2013.Search in Google Scholar

13. Lin-Chu M, Broadberry RE, Chang FJ. The distribution of blood group antigens and alloantibodies among Chinese in Taiwan. Transfusion 1988;28:350–2.10.1046/j.1537-2995.1988.28488265265.xSearch in Google Scholar

14. Lalueza-Fox C, Gigli E, de la Rasilla M, Fortea J, Rosas A, Bertranpetit J, et al. Genetic characterization of the ABO blood group in Neandertals. BMC Evol Biol 2008;8:342.10.1186/1471-2148-8-342Search in Google Scholar

15. Crainic K, Durigon M, Oriol R. ABO tissue antigens of Egyptian mummies. Forensic Sci Int 1989;43:113–24.10.1016/0379-0738(89)90130-8Search in Google Scholar PubMed

16. Fry AE, Griffiths MJ, Auburn S, Diakite M, Forton JT, Green A, et al. Common variation in the ABO glycosyltransferase is associated with susceptibility to severe Plasmodium falciparum malaria. Hum Mol Genet 2007;17:567–76.10.1093/hmg/ddm331Search in Google Scholar PubMed PubMed Central

17. Borén T, Falk P, Roth KA, Larson G, Normark S. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993;262:1892–5.10.1126/science.8018146Search in Google Scholar PubMed

18. Swerdlow DL, Mintz ED, Rodriguez M, Tejada E, Ocampo C, Espejo L, et al. Severe life-threatening cholera associated with blood group O in Peru: implications for the Latin American epidemic. J Infect Dis 1994;170:468–72.10.1093/infdis/170.2.468Search in Google Scholar PubMed

19. Yamamoto F. Review: ABO blood group system – ABH oligosaccharide antigens, anti-A and anti-B, A and B glycosyltransferases, and ABO genes. Immunohematology 2004;20:3–22.10.21307/immunohematology-2019-418Search in Google Scholar

20. Schiff F, Sasaki H. Der Ausscheidungstypus ein auf Serologischem Wege Nachweirbares Mendelndes merkaml. Klin Wochenschr 1932;11:1426–9.10.1007/BF01987492Search in Google Scholar

21. Kelly RJ, Ernst LK, Larsen RD, Bryant JG, Robinson JS, Lowe JB. Molecular basis for H blood group deficiency in Bombay (Oh) and para-Bombay individuals. Proc Natl Acad Sci USA 1994;91:5843–7.10.1073/pnas.91.13.5843Search in Google Scholar PubMed PubMed Central

22. Bhende YM, Deshpande CK, Bhatia HM, Sanger R, Race RR, Morgan WT, et al. A “new” blood group character related to the ABO system. Lancet 1952;1:903–4.Search in Google Scholar PubMed

23. Yamamoto F, Clausen H, White T, Marken J, Hakomori S. Molecular genetic basis of the histo-blood group ABO system. Nature 1990;345:229–33.10.1038/345229a0Search in Google Scholar PubMed

24. Kermarrec N, Roubinet F, Apoil PA, Blancher A. Comparison of allele O sequences of the human and non-human primate ABO system. Immunogenetics 1999;49:517–26.10.1007/s002510050529Search in Google Scholar PubMed

25. Beattie KM. Discrepancies in ABO grouping. In: American Association of Blood Banks, editor. A seminar on problems encountered in pretranfusion tests. Washington, DC: American Association of Blood Banks, 1972: 129–65.Search in Google Scholar

26. Hosoi E. Biological and clinical aspects of ABO blood group system. J Med Invest 2008;55:174–82.10.2152/jmi.55.174Search in Google Scholar PubMed

27. International Society of Blood Transfusion (ISBT). Blood Group Terminology. Table of blood group systems. Available from: http://www.isbtweb.org/fileadmin/user_upload/WP_on_Red_Cell_Immunogenetics_and/Table_of_blood_group_systems_v3.0_121028.pdf. Accessed on 2 March, 2013.Search in Google Scholar

28. Società Italiana di Medicina Trasfusionale e Immunoematologia (SIMTI), editor. Standards of Transfusion Medicine, 2nd ed. Milan: SIMTI Servizi srl, 2010:156. Available from: http://www.simti.it/pdf/Standard_EN_protetto.pdf. Accessed 2 Mar, 2013.Search in Google Scholar

29. Gerbal A, Maslet C, Salmon C. Immunologic aspects of the acquired-B antigen. Vox Sang 1975;28:398–403.10.1111/j.1423-0410.1975.tb02787.xSearch in Google Scholar PubMed

30. Josephson CD, Mullis NC, Van Demark C, Hillyer CD. Significant numbers of apheresis-derived group O platelet units have “high-titer” anti-A/A,B: implications for transfusion policy. Transfusion 2004;44:805–8.10.1111/j.1537-2995.2004.03290.xSearch in Google Scholar PubMed

31. Sapatnekar S, Sharma G, Downes KA, Wiersma S, McGrath C, Yomtovían R. Acute hemolytic transfusion reaction in a pediatric patient following transfusion of apheresis platelets. J Clin Apher 2005;20:225–9.10.1002/jca.20072Search in Google Scholar PubMed

32. Bolton-Maggs PH, editor, Cohen H, on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group. The 2011 Annual SHOT Report (2012). Available from: http://www.shotuk.org/wp-content/uploads/2012/07/SHOT-ANNUAL-REPORT_FinalWebVersionBookmarked_2012_06_22.pdf. Accessed on 4 April, 2013.Search in Google Scholar

33. Liumbruno G, Bennardello F, Lattanzio A, Piccoli P, Rossetti G, Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) Work Group. Recommendations for the transfusion of plasma and platelets. Blood Transfus 2009;7:132–50.Search in Google Scholar PubMed

34. Cooling L. ABO and platelet transfusion therapy. Immunohematology 2007;23:20–33.10.21307/immunohematology-2019-314Search in Google Scholar PubMed

35. Liumbruno G, Bennardello F, Lattanzio A, Piccoli P, Rossetti G. Recommendations for the transfusion of red blood cells. Blood Transfus 2009;7:49–64.Search in Google Scholar PubMed

36. Tormey CA. Transfusion support for hematopoietic stem cell transplant recipients. In: Roback JD, Grossman BJ, Harris T, Hillyer CD, editors. Technical manual, 17th ed. Betheshda: AABB, 2011:687–705.Search in Google Scholar

37. Yazer MH, Triulzi DJ. Immune hemolysis following ABO-mismatched stem cell or solid organ transplantation. Curr Opin Hematol 2007;14:664–70.10.1097/MOH.0b013e3282e9a576Search in Google Scholar PubMed

38. Sassi M, Maggiore U, Buzio C, Franchini M. Immunohaematological and apheretic aspects of the first kidney transplant from a living, ABO-incompatible donor carried out in Italy. Blood Transfus 2011;9:218–24.Search in Google Scholar PubMed

39. Clarke CA. Blood group and disease. In: Steiberg AG, editor. Progress in medical genetics, Vol. 1. New York: Grune and Stratton, 1961:81–119.Search in Google Scholar

40. Edgren G, Hjalgrim H, Rostgaard K, Norda R, Wikman A, Melbye M, et al. Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol 2010;172:1280–5.10.1093/aje/kwq299Search in Google Scholar PubMed

41. Wang Z, Liu L, Ji J, Zhang J, Yan M, Zhang J, et al. ABO blood group system and gastric cancer: a case-control study and meta-analysis. Int J Mol Sci 2012;13:13308–31.10.3390/ijms131013308Search in Google Scholar PubMed PubMed Central

42. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet 2009;41:986–90.10.1038/ng.429Search in Google Scholar PubMed PubMed Central

43. Wolpin BM, Chan AT, Hartge P, Chanock SJ, Kraft P, Hunter DJ, et al. ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst 2009;101:424–31.10.1093/jnci/djp020Search in Google Scholar PubMed PubMed Central

44. Risch HA, Yu H, Lu L, Kidd MS. ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study. J Natl Cancer Inst 2010;102:502–5.10.1093/jnci/djq007Search in Google Scholar PubMed PubMed Central

45. Xie J, Qureshi AA, Li Y, Han J. ABO blood group and incidence of skin cancer. PloS One 2010;5:e11972.10.1371/journal.pone.0011972Search in Google Scholar PubMed PubMed Central

46. Gates MA, Wolpin BM, Cramer DW, Hankinson SE, Tworoger SS. ABO blood group and incidence of epithelial ovarian cancer. Int J Cancer 2011;128:482–6.10.1002/ijc.25339Search in Google Scholar PubMed PubMed Central

47. Lee JS, Ro JY, Sahin AA, Hong WK, Brown BW, Mountain CF, et al. Expression of blood-group antigen A – a favorable prognostic factor in non-small-cell lung cancer. N Engl J Med 1991;324:1084–90.10.1056/NEJM199104183241603Search in Google Scholar

48. Khalili H, Wolpin BM, Huang ES, Giovannucci EL, Kraft P, Fuchs CS, et al. ABO blood group and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2011;20:1017–29.10.1158/1055-9965.EPI-10-1250Search in Google Scholar PubMed

49. Gates MA, Xu M, Chen WY, Kraft P, Hankinson SE, Wolpin BM. ABO blood group and breast cancer incidence and survival. Int J Cancer 2012;130:2129–37.10.1002/ijc.26220Search in Google Scholar PubMed

50. Preston AE, Barr A. The plasma concentration of factor VIII in the normal population. Br J Haematol 1964;10:238–45.10.1111/j.1365-2141.1964.tb00698.xSearch in Google Scholar PubMed

51. Moeller A, Weippert-Kretschmer M, Prinz H, Kretschmer V. Influence of ABO blood groups on primary hemostasis. Transfusion 2001;41:56–60.10.1046/j.1537-2995.2001.41010056.xSearch in Google Scholar PubMed

52. O’Donnell JS, Lasffan MA. The relationship between ABO histo-blood group, factor VIII and von Willebrand factor. Transfus Med 2001;11:343–51.10.1046/j.1365-3148.2001.00315.xSearch in Google Scholar

53. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987;69:1691–5.10.1182/blood.V69.6.1691.bloodjournal6961691Search in Google Scholar PubMed

54. Matsui T, Titani K, Mizuochi T. Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures. J Biol Chem 1992;267:8723–31.10.1016/S0021-9258(19)50338-6Search in Google Scholar

55. Sodetz JM, Pizzo SV, McKee PA. Relationship of sialic acid to function and in vivo survival of human factor VIII/von Willebrand factor protein. J Biol Chem 1977;252:5538–46.10.1016/S0021-9258(19)63384-3Search in Google Scholar PubMed

56. Jenkins PV, O’Donnell JS. ABO blood group determines plasma von Willebrand factor levels: a biologic function after all? Transfusion 2006;46:1836–44.10.1111/j.1537-2995.2006.00975.xSearch in Google Scholar PubMed

57. Wu O, Bayoumi N, Vickers MA, Clark P. ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost 2008;6:62–9.10.1111/j.1538-7836.2007.02818.xSearch in Google Scholar PubMed

58. Dentali F, Sironi AP, Ageno W, Turato S, Bonfanti C, Frattini F, et al. Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature. Semin Thromb Hemost 2012;38:535–48.10.1055/s-0032-1315758Search in Google Scholar PubMed

59. He M, Wolpin B, Rexrode K, Manson JE, Rimm E, Hu FB, et al. ABO blood group and risk of coronary heart disease in two prospective cohort studies. Arterioscler Thromb Vasc Biol 2012;32:2314–20.10.1161/ATVBAHA.112.248757Search in Google Scholar PubMed PubMed Central

60. Franchini M, Rossi C, Mengoli C, Frattini F, Crestani S, Giacomini I, et al. ABO blood group and the risk of coronary artery disease. J Thromb Thrombolysis 2012; DOI: 10.1007/s11239-012-0836-1.10.1007/s11239-012-0836-1Search in Google Scholar PubMed

Received: 2013-03-05
Accepted: 2013-04-08
Published Online: 2013-05-07
Published in Print: 2013-08-01

©2013 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Letters to the Editors
  2. Clinical utility of serum tumor markers and cytokines in cervical cancer and neoplasia
  3. Establishing reference intervals for LDL subfractions in a Korean population using the Lipoprint LDL system
  4. Measurement imprecision of common urinary biochemical analytes on the Roche Cobas 6000 system
  5. A comparison between turbidimetric inhibition immunoassay and capillary electrophoresis in glycated hemoglobin (HbA1c) measurement
  6. Commutability: a peculiar property of calibration and control materials. Definition and evaluation
  7. Diagnostic sensitivity of a panel of tests to detect monoclonal protein in Korean multiple myeloma patients
  8. Commutability of proficiency testing (PT): status of the matrix-related bias in general clinical chemistry
  9. Masthead
  10. Masthead
  11. Editorial
  12. Why specifications for allowable glucose meter errors should include 100% of the data
  13. Reviews
  14. ABO blood group: old dogma, new perspectives
  15. Trace elements and bone health
  16. Mini Review
  17. The role of transcription factors in laboratory medicine
  18. Opinion Papers
  19. Nobelitis: a common disease among Nobel laureates?
  20. The syndrome of the “obsessive-compulsory scientist”: a new mental disorder?
  21. Can current analytical quality performance of UK clinical laboratories support evidence-based guidelines for diabetes and ischaemic heart disease? – A pilot study and a proposal
  22. Guidelines and Recommendations
  23. Survey of national guidelines, education and training on phlebotomy in 28 European countries: an original report by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) working group for the preanalytical phase (WG-PA)
  24. General Clinical Chemistry and Laboratory Medicine
  25. Red cell indices: differentiation between β-thalassemia trait and iron deficiency anemia and application to sickle cell disease and sickle cell thalassemia
  26. Problems in determining thalassemia carrier status in a program for prevention and control of severe thalassemia syndromes: a lesson from Thailand
  27. An enzyme linked immunosorbent assay (ELISA) for the determination of the human haptoglobin phenotype
  28. Blood loss from laboratory diagnostic tests in children
  29. Hematocrit correction does not improve glucose monitor accuracy in the assessment of neonatal hypoglycemia
  30. Evaluation of a mobile clinical pathology laboratory developed for the home care of pediatric patients following transplantation of peripheral blood precursor cells
  31. Folic acid supplementation does not reduce intracellular homocysteine, and may disturb intracellular one-carbon metabolism
  32. Influence of spurious hemolysis on blood gas analysis
  33. Serum procalcitonin predicts development of acute kidney injury in patients with suspected infection
  34. Reference Values and Biological Variations
  35. Nationwide multicenter study aimed at the establishment of common reference intervals for standardized clinical laboratory tests in Japan
  36. Cancer Diagnostics
  37. Application of BRAF, NRAS, KRAS mutations as markers for the detection of papillary thyroid cancer from FNAB specimens by pyrosequencing analysis
  38. Comparative evaluation of the My5-FU™ immunoassay and LC-MS/MS in monitoring the 5-fluorouracil plasma levels in cancer patients
https://doi.org/10.1515/cclm-2013-0168
Keywords for this article
ABO blood group; cancer; cardiovascular disorders; thrombosis; von Willebrand factor

Articles in the same Issue

  1. Letters to the Editors
  2. Clinical utility of serum tumor markers and cytokines in cervical cancer and neoplasia
  3. Establishing reference intervals for LDL subfractions in a Korean population using the Lipoprint LDL system
  4. Measurement imprecision of common urinary biochemical analytes on the Roche Cobas 6000 system
  5. A comparison between turbidimetric inhibition immunoassay and capillary electrophoresis in glycated hemoglobin (HbA1c) measurement
  6. Commutability: a peculiar property of calibration and control materials. Definition and evaluation
  7. Diagnostic sensitivity of a panel of tests to detect monoclonal protein in Korean multiple myeloma patients
  8. Commutability of proficiency testing (PT): status of the matrix-related bias in general clinical chemistry
  9. Masthead
  10. Masthead
  11. Editorial
  12. Why specifications for allowable glucose meter errors should include 100% of the data
  13. Reviews
  14. ABO blood group: old dogma, new perspectives
  15. Trace elements and bone health
  16. Mini Review
  17. The role of transcription factors in laboratory medicine
  18. Opinion Papers
  19. Nobelitis: a common disease among Nobel laureates?
  20. The syndrome of the “obsessive-compulsory scientist”: a new mental disorder?
  21. Can current analytical quality performance of UK clinical laboratories support evidence-based guidelines for diabetes and ischaemic heart disease? – A pilot study and a proposal
  22. Guidelines and Recommendations
  23. Survey of national guidelines, education and training on phlebotomy in 28 European countries: an original report by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) working group for the preanalytical phase (WG-PA)
  24. General Clinical Chemistry and Laboratory Medicine
  25. Red cell indices: differentiation between β-thalassemia trait and iron deficiency anemia and application to sickle cell disease and sickle cell thalassemia
  26. Problems in determining thalassemia carrier status in a program for prevention and control of severe thalassemia syndromes: a lesson from Thailand
  27. An enzyme linked immunosorbent assay (ELISA) for the determination of the human haptoglobin phenotype
  28. Blood loss from laboratory diagnostic tests in children
  29. Hematocrit correction does not improve glucose monitor accuracy in the assessment of neonatal hypoglycemia
  30. Evaluation of a mobile clinical pathology laboratory developed for the home care of pediatric patients following transplantation of peripheral blood precursor cells
  31. Folic acid supplementation does not reduce intracellular homocysteine, and may disturb intracellular one-carbon metabolism
  32. Influence of spurious hemolysis on blood gas analysis
  33. Serum procalcitonin predicts development of acute kidney injury in patients with suspected infection
  34. Reference Values and Biological Variations
  35. Nationwide multicenter study aimed at the establishment of common reference intervals for standardized clinical laboratory tests in Japan
  36. Cancer Diagnostics
  37. Application of BRAF, NRAS, KRAS mutations as markers for the detection of papillary thyroid cancer from FNAB specimens by pyrosequencing analysis
  38. Comparative evaluation of the My5-FU™ immunoassay and LC-MS/MS in monitoring the 5-fluorouracil plasma levels in cancer patients
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 22.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2013-0168/html
Scroll to top button